Welcome to Buzzkill Labs, the forefront of modernizing drug testing in a legalized world. With a visionary founder, Jeff Heimburger, an undisclosed Series A funding from soon-to-be-revealed investors, we are poised to revolutionize biotechnology research. The evolving legislation legalizing recreational cannabis has created a market demand for rapid and accurate drug testing technology, and Buzzkill Labs is here to meet that need. Their groundbreaking approach combines patented noninvasive sample collection with scientifically validated laboratory detection and quantitation technology. 

Addressing the crucial areas of workplace safety, suspected impaired driving, and fast, accurate testing by medical and drug treatment centers, Buzzkill Labs products are at the forefront of innovation. Gone are the days of needles and invasive procedures. Our technology utilizes oral fluid (saliva) for testing, offering a simple, painless, and representative sample of THC concentration in the body. With our advanced separation techniques, we ensure accurate analysis by distinguishing between psychoactive and non-psychoactive compounds. Quantitative and precise, our technology provides critical information about drug levels in a person's system at the time of testing, assisting law enforcement and employers alike. Join us at Buzzkill Labs as we redefine drug testing for a legalized world.